ClinicalThought

Share

Program Content

Activities

  • Frontline IO Combos
    What’s New Regarding Frontline Immunotherapy Combinations in Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 30, 2019

    Expires: December 28, 2020

  • IO for Squamous NSCLC
    Using Immunotherapy to Treat Advanced Squamous NSCLC: Where Are We Now?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 24, 2020

    Expires: February 22, 2021

  • Biomarker Testing in Advanced NSCLC
    My Approach to Biomarker Testing in Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 11, 2020

    Expires: May 10, 2021

  • Dual IO for NSCLC
    My Take on the Recent Approval of Dual Immune Checkpoint Inhibition for Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 06, 2020

    Expires: July 05, 2021

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Celgene

Loxo Oncology subsidiary of Eli Lilly

Partners

GRACE

ProCE Banner